Germing U - Search Results

1

Germline variants drive myelodysplastic syndrome in young adults.

Feurstein S, Churpek JE, Walsh T, Keel S, Hakkarainen M, Schroeder T, Germing U, Geyh S, Heuser M, Thol F, Pohlkamp C, Haferlach T, Gao J, Owen C, Goehring G, Schlegelberger B, Verma D, Krause DS, Gao G, Cronin T, Gulsuner S, Lee M, Pritchard CC, Subramanian HP, Del Gaudio D, Li Z, Das S, Kilpivaara O, Wartiovaara-Kautto U, Wang ES, Griffiths EA, Döhner K, Döhner H, King MC, Godley LA. Feurstein S, et al. Among authors: germing u. Leukemia. 2021 Aug;35(8):2439-2444. doi: 10.1038/s41375-021-01137-0. Epub 2021 Jan 28. Leukemia. 2021. PMID: 33510405 Free PMC article. No abstract available.

2

Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.

Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Aul C, et al. Among authors: germing u. Leukemia. 1992 Jan;6(1):52-9. Leukemia. 1992. PMID: 1736014

3

Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score.

Aul C, Gattermann N, Germing U, Runde V, Heyll A, Schneider W. Aul C, et al. Among authors: germing u. Leukemia. 1994 Nov;8(11):1906-13. Leukemia. 1994. PMID: 7967735

4

Increasing incidence of myelodysplastic syndromes: real or fictitious?

Aul C, Germing U, Gattermann N, Minning H. Aul C, et al. Among authors: germing u. Leuk Res. 1998 Jan;22(1):93-100. doi: 10.1016/s0145-2126(97)00089-1. Leuk Res. 1998. PMID: 9585086

5

Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients.

Germing U, Gattermann N, Strupp C, Aivado M, Aul C. Germing U, et al. Leuk Res. 2000 Dec;24(12):983-92. doi: 10.1016/s0145-2126(00)00088-6. Leuk Res. 2000. PMID: 11077111

6

Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma.

Misgeld E, Germing U, Aul C, Gattermann N. Misgeld E, et al. Among authors: germing u. Leuk Res. 2001 Jan;25(1):95-98. doi: 10.1016/s0145-2126(00)00092-8. Leuk Res. 2001. PMID: 11137566

7

Thalidomide for the treatment of patients with myelodysplastic syndromes.

Strupp C, Germing U, Aivado M, Misgeld E, Haas R, Gattermann N. Strupp C, et al. Among authors: germing u. Leukemia. 2002 Jan;16(1):1-6. doi: 10.1038/sj.leu.2402330. Leukemia. 2002. PMID: 11840256

8

The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML.

Kaeferstein A, Krug U, Tiesmeier J, Aivado M, Faulhaber M, Stadler M, Krauter J, Germing U, Hofmann WK, Koeffler HP, Ganser A, Verbeek W. Kaeferstein A, et al. Among authors: germing u. Leukemia. 2003 Feb;17(2):343-9. doi: 10.1038/sj.leu.2402805. Leukemia. 2003. PMID: 12592334

9

Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.

Strupp C, Gattermann N, Giagounidis A, Aul C, Hildebrandt B, Haas R, Germing U. Strupp C, et al. Among authors: germing u. Leuk Res. 2003 May;27(5):397-404. doi: 10.1016/s0145-2126(02)00220-5. Leuk Res. 2003. PMID: 12620291

10

Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31.

Giagounidis AA, Germing U, Haase S, Hildebrandt B, Schlegelberger B, Schoch C, Wilkens L, Heinsch M, Willems H, Aivado M, Aul C. Giagounidis AA, et al. Among authors: germing u. Leukemia. 2004 Jan;18(1):113-9. doi: 10.1038/sj.leu.2403189. Leukemia. 2004. PMID: 14586479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters